Correlation Between Sana Biotechnology and Spyre Therapeutics
Can any of the company-specific risk be diversified away by investing in both Sana Biotechnology and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sana Biotechnology and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sana Biotechnology and Spyre Therapeutics, you can compare the effects of market volatilities on Sana Biotechnology and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sana Biotechnology with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sana Biotechnology and Spyre Therapeutics.
Diversification Opportunities for Sana Biotechnology and Spyre Therapeutics
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Sana and Spyre is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Sana Biotechnology and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Sana Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sana Biotechnology are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Sana Biotechnology i.e., Sana Biotechnology and Spyre Therapeutics go up and down completely randomly.
Pair Corralation between Sana Biotechnology and Spyre Therapeutics
Given the investment horizon of 90 days Sana Biotechnology is expected to under-perform the Spyre Therapeutics. In addition to that, Sana Biotechnology is 1.44 times more volatile than Spyre Therapeutics. It trades about -0.21 of its total potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.04 per unit of volatility. If you would invest 2,771 in Spyre Therapeutics on September 25, 2024 and sell it today you would lose (385.00) from holding Spyre Therapeutics or give up 13.89% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Sana Biotechnology vs. Spyre Therapeutics
Performance |
Timeline |
Sana Biotechnology |
Spyre Therapeutics |
Sana Biotechnology and Spyre Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sana Biotechnology and Spyre Therapeutics
The main advantage of trading using opposite Sana Biotechnology and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sana Biotechnology position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.Sana Biotechnology vs. Fate Therapeutics | Sana Biotechnology vs. Caribou Biosciences | Sana Biotechnology vs. Arcus Biosciences | Sana Biotechnology vs. Karyopharm Therapeutics |
Spyre Therapeutics vs. AKITA Drilling | Spyre Therapeutics vs. Joint Stock | Spyre Therapeutics vs. Q2 Holdings | Spyre Therapeutics vs. Ultra Clean Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |